SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The $CAW.X (crow with knife) crypto is trending as the community rallies around its multichain capabilities and deflationary mechanics, with some users pointing to potential for millionaires to be minted. Community members are also discussing partnerships with platforms like Stargate and Layerzero, while highlighting its presence across $SOL.X, $CRO.X, and $ETH.X.

PHUMPTOM (PHUM) is a meme token, the symbol of which is a phantom. The story of this character is built around trading, and according to legend, he was born on the pump platform.fun from the energy of green candles. Now it is a symbol of green charts, the keeper of green candles. His presence portends growth, and he brings good luck to traders.  A positive character who tells his story like an adventure, generates memes where he always rushes to the aid of traders and gives good luck to holders.

PHUMPTOM

$PHUM.X is trending as the community rallies behind it, emphasizing early entry for potential gains. The crypto is associated with the Solana ecosystem, and traders are actively discussing its chart patterns and potential for a significant move, using terms like 'rocket loading' and 'moon tickets ready'.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis is trending due to recent price surges and high trading volume, sparking excitement within the community. Discussions revolve around its potential as a hidden gem, with some drawing comparisons to established cryptocurrencies and highlighting its underlying utility. Community members are actively debating holding strategies versus profit-taking amid volatility.

Biggie is a popular Pitbull across several social media platforms, such as Tiktok, Youtube and Instagram. With a blend of creativity and comedic gestures, Biggie brings animal loving entertainment to millions of viewers through images, videos and reels. With Biggie the Pitbull's growing popularity, the meme coin $BIGGIE was inspired and launched on the ethereum network, leveraging Biggies unique sense of humor and style.

Biggie

BIGGIE.X is trending as investors discuss its potential, drawing comparisons to other meme coins like SHIB and WEN. The community highlights the project's team and anticipates further growth, with some members sharing their recent purchases and expressing bullish sentiment. Some users are also comparing it to other trending cryptos.

What is the project about? Vara Network is a substrate-based future proof smart contract platform that is fast, scalable, and makes it simple to create and deploy next-generation Web3.0 dApps Vara is the first standalone network in the Gear Protocol  Gear is a next-gen cloud infrastructure platform providing most intuitive and frictionless environment for web2 and web3 developers to build complex infrastructure solutions and disruptive dApps for any ecosystem  What makes your project unique? Vara is built upon three core concepts: The actor model, and persistent memory — two widely adopted primitives from massive computation and microservices architecture spaces  Wasm — a WebAssembly-based virtual machine that runs on all modern browsers. Proven to be faster than any alternative web2 virtual machines  Vara was created to serve as a wasm-native hub for innovative protocols that leverage parallel execution and asynchronous programming to deliver leading decentralized products in any segment  History of your project. Gear Protocol and the Vara Network were originally created by Nikolay Volf, one of the core developers of Polkadot. In 2021, he embarked on building an advanced layer 1 smart contract platform using Substrate, Polkadot's custom framework. His vision included creating a platform that enables fast and efficient execution of robust, feature-rich dApps while in a seamless development environment similar to that of Web 2.0 development. He did this by  harnessing the power of innovative technologies like Wasm, the Actor Model, and Persistent Memory. These technologies significantly enhance smart contract development and provide a seamless end-user experience and provide the foundation for the development of Vara Network.  1. Q2 2021 - Pre-Seed Round: In the second quarter of 2021, the Protocol secured its initial funding through a pre-seed round. This likely involved seeking investment from early-stage investors or venture capitalists to kickstart the development of the project.  2. Q4 2021 - Seed Round: In December 2021 raised $12 Million in Venture Round. Private investment round led by Blockchange Venture. In addition to Blockchange, other top venture capital funds participated in this round, including Three  Arrows Capital, Lemniscap, Distributed Global, LAO, Mechanism Capital, Bitscale, Spartan Group LLC, HashKey, DI Ventures, Elysium Venture Capital, Signum Capital and P2P Economy lead by Konstantin Lomashuk, along with a number of top executives of Web3 Foundation and Parity Technologies. Dr. Gavin Wood, Founder and ex-CEO of Parity Technologies and one of the key individual investors participating in this round.  3. 2022 - Intensive Scaling and Development, First Test Integrations: Throughout the year 2022, Vara was focused on two primary activities. First, the engagement in an extensive outreach process to build up the team. Second, the project advanced its technical development efforts and started working on integrating their technology with various test environments to ensure its functionality and viability.  4. Q4 2022 - Testnet Launch.   5. Q1 2023 - PoA Launch: In the first quarter of 2023, Vara achieved launch of its Proof of Authority (PoA) consensus network, which is a chain candidate for mainnet.  Current Status of Vara:  Presently, the project boasts a talented and diverse decentralized workforce, consisting of dozens of engineers and other community members  to drive the project's success.  One of the remarkable aspects of Vara is its substantial pipeline of initiatives with over 40 projects.  What’s next for your project? Current projects being researched and developed by the community:  - Intensive testing and improvement of the actor model features in the blockchain space  - Launch of the key stack of dApps in our parallel and asynchronous environment   - Development of innovative infrastructure solutions (e.g offchain zk actors including machine learning) independently and together with the segment leaders  What can your token be used for? VARA tokens maintain core utility features required for the network to operate: transaction fees staking and network security governance other: gas pools for gas reservation  Contributors to the Gear protocol are exploring the mechanics of how to distribute a portion of block rewards directly toward dApp developers

Vara Network

Vara Network is trending amid mixed sentiment, with some community members expressing frustration over price action and token unlocks, while others point to staking rewards and potential for long-term growth as reasons to accumulate. Discussions also focus on the project's fundamentals, including its layer-1 status, upcoming developments, and a potential Ethereum bridge. Some traders are watching for a breakout and accumulating, while others are wary of further price declines.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to community excitement around a recently announced AI server contract. Traders are actively discussing the stock's potential for a short squeeze, citing its low float and high borrow fees. Some investors believe that ARBB is undervalued given its recent deals and cash position.

Jupiter is a cryptocurrency exchange platform on the Solana blockchain, offering features such as token swapping, limit orders, dollar-cost averaging, and a bridge for asset transfers to Solana. It provides users with tools to find the best trading prices and includes a beta version for perpetual futures trading. Jupiter finds the best price route for your swap by aggregating all the major liquidity sources on Solana.

Jupiter

$UPDOG.X, built on Solana and available on Jupiter ($JUP.X), is gaining traction with its community citing relentless development and a strong holder base. Active community members are emphasizing its presence on the Jupiter Strict List and encouraging others to load up on the token. The coin is being touted as a joke meta pioneer with locked and burned LP, aiming for exponential growth.

WorldFinancial

WorldFinancial ($WLFI.X) is trending amid discussions about its potential, coin burns, and upcoming app release. Community members are actively debating price predictions, while some express concerns about volatility and insider selling. The crypto's connection to the Trump family and ALT 5 Sigma ($ALTS) is also a hot topic.

Progressive Corp. is an insurance holding company, which engages in the provision of personal and commercial auto insurance, residential property insurance, and other specialty property-casualty insurance and related services. It operates through the following segments: Personal Lines, Commercial Lines, and Property. The Personal Lines segment includes agency and direct businesses. The Commercial Lines segment writes primary liability and physical damage insurance for automobiles and trucks owned and operated predominately by small business in the auto, for-hire transportation, contractor, for-hire specialty, tow, and for-hire livery markets. The Property segment covers residential property insurance for homeowners, other property owners, and renters. The company was founded on March 10, 1937, and is headquartered in Mayfield Village, OH.

Progressive Corp.

Progressive Corp

Progressive ($PGR) is trending due to strong earnings and analyst upgrades, with the community actively discussing its potential for continued growth and outperformance in the insurance sector. Rate hikes in Nevada are also contributing to the buzz, positioning insurance stocks as potentially strong plays. Community members are also comparing Progressive's disciplined underwriting and compounding characteristics to other insurers.

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: House of Brands and Commercial and Wholesale. The House of Brands segment includes multiple categories including food and beverage, nutraceuticals, cannabis accessories and technology, personal care and wellness. The Commercial and Wholesale segment includes distribution of pharmaceutical products to international markets. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Flora Growth Corp

FLGC is trending following news of a $401 million funding round to power its AI treasury strategy and rebrand as ZeroStack. The community is discussing the potential for a gap up and comparing it to other high-flying stocks. Some express concern about the company's financials while others focus on potential catalysts such as marijuana rescheduling and the company's cryptocurrency holdings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NVCR Stock Slips Despite PMA Application to Treat Pancreatic Cancer

NovoCure submits a PMA to the FDA for TTFields therapy in pancreatic cancer, aiming to expand its oncology reach.

NovoCure (NVCR) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for NovoCure (NVCR) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates

NovoCure (NVCR) delivered earnings and revenue surprises of +7.69% and +3.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

NovoCure (NVCR) Soars 5.3%: Is Further Upside Left in the Stock?

NovoCure (NVCR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

What Makes NovoCure (NVCR) a New Buy Stock

NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial

Does NovoCure (NVCR) Have the Potential to Rally 105.5% as Wall Street Analysts Expect?

Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update

Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial and operational results for the quarter and full year ended December 31, 2024. Novocure is a global oncology company working to...

Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference

Novocure (NASDAQ: NVCR) announced today that management will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025. Ashley Cordova, Chief Executive Officer...

Shares of Novocure Ltd. skyrocketed over 55% on Monday afternoon, reaching levels last seen in August 2023, as the company announced promising Phase 3 trial results for its Tumor Treating Fields (TTFields) therapy.&nbsp;Trading volume surged to more than seven times the daily average, underscoring heightened investor interest.The pivotal PANOVA-3 trial, conducted jointly by Novocure and Zai Lab, evaluated TTFields therapy in combination with gemcitabine and nab-paclitaxel as a first-line treatment for unresectable, locally advanced pancreatic adenocarcinoma.&nbsp;The trial met its primary endpoint, showing a statistically significant improvement in median overall survival (mOS).&nbsp;Patients receiving TTFields alongside the standard chemotherapy regimen achieved an mOS of 16.2 months, compared to 14.2 months for those treated with chemotherapy alone, marking a two-month survival advantage.&nbsp;Additionally, TTFields demonstrated a 33% improvement in the survival rate at 24 months, with the therapy being well-tolerated and exhibiting a consistent safety profile.TTFields therapy, an FDA-approved treatment designed to disrupt cancer cell division using electric fields, is already under investigation for multiple cancer types, including glioblastoma and mesothelioma.&nbsp;Novocure plans to seek regulatory approval for TTFields in pancreatic cancer based on the PANOVA-3 data and aims to present the findings at an upcoming medical congress.&nbsp;Zai Lab intends to file for regulatory approval in China.<figure class="image"><a href="https://stocktwits.com/symbol/NVCR"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/NVCR_sentiment_meter_and_message_volume_on_Dec_2_dd14a0b3d0.png" alt="NVCR sentiment meter and message volume on Dec 2.png" width="1314" height="320"></a><figcaption>NVCR sentiment meter and message volume on Dec 2 as of 2:20 pm ET | source: Stocktwits</figcaption></figure>Retail investors reacted enthusiastically on Stocktwits, propelling sentiment for Novocure to ‘extremely bullish’ as message volumes soared.&nbsp;<stembedurl>https://stocktwits.com/vandy84/message/594738690</stembedurl><stembedurl>https://stocktwits.com/Chazdaq/message/594725063</stembedurl>Wall Street analysts also took notice. H.C. Wainwright raised its price target on Novocure to $38 from $30, highlighting the significant market opportunity in pancreatic cancer and projecting global peak sales of $1.7 billion by 2037.&nbsp;Leerink lifted its target to $33 from $28, citing the potential revenue upside from TTFields indications in non-small cell lung cancer and glioblastoma.&nbsp;Ahead of the trial readout on Monday, Evercore ISI upgraded Novocure to ‘Outperform’ from ‘In Line’ and raised the price target to $30 from $18. The brokerage said if it were to assume about 50% probability for success, it would lead to peak revenue of greater than $500 million and about 30% penetration, with about 50% upside to NVCR shares in a base case.Looking ahead, Novocure is continuing its exploration of TTFields in metastatic pancreatic cancer through the ongoing PANOVA-4 Phase 2 trial. The study, which combines TTFields with atezolizumab, gemcitabine, and nab-paclitaxel, has completed enrollment, with data expected in 2026.Novocure’s shares have gained over 115% year-to-date, positioning the company for renewed momentum in the biotech sector.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tsla-stock-rises-after-upgrade-price-target-hikes/cJ9kq43RhE">Tesla Stock Rises After Massive Price Target Hikes On Trump, AI Factors: Retail’s Charged Up</a>

Novocure plans to seek regulatory approval for TTFields in pancreatic cancer based on the PANOVA-3 data and aims to present the findings at an upcoming medical congress. 

Novocure Stock Soars On Positive Pancreatic Cancer Trial Results, Retail Sentiment Surges

The trial met its primary endpoint, showing a statistically significant improvement in median overall survival.

Equity

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

NovoCure Ltd

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

NVCR
NovoCure Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest NVCR News

NVCR NovoCure Ltd